The role of ALK genetic aberrations in human carcinogenesis was widely recognized upon discovery of the nucleophosmin (NPM)-ALK gene fusion in anaplastic large cell lymphoma (ALCL) in 1994 [6]. The gene discussed is ALK; the disease is anaplastic large cell lymphoma.